Literature DB >> 31090035

Arteritis after administration of granulocyte colony-stimulating factor: a case series.

Ken Sasaki1, Masashi Miyauchi1, Mizuki Ogura1, Arika Shimura-Nukina1, Kazuhiro Toyama1, Kumi Nakazaki1, Takeyuki Watadani2, Osamu Abe2, Mineo Kurokawa3,4.   

Abstract

Granulocyte colony-stimulating factor (G-CSF) is commonly administered to prevent serious complications caused by chemotherapy-induced neutropenia; however, several cases of arteritis following the administration of G-CSF have been reported. Here, we report three cases of patients with non-Hodgkin lymphomas (NHLs) who developed arteritis after the administration of G-CSF, estimate the probability of adverse drug reaction caused by G-CSF with two distinct algorithms, and review the literatures. Both algorithms indicated a causal relationship between G-CSF and arteritis. In a literature review of seven reported cases, including our three patients, the time from the administration of G-CSF to the onset of arteritis ranged from 9 days to 6 months, and five patients were treated with steroids. In one of our three cases, a 62-year-old female with NHL developed arteritis twice in different courses of chemotherapy. Hydrocortisone was administered in the second event, leading to prompt relief of the manifestation and abnormal laboratory data. This finding suggests steroids may be effective for arteritis. In conclusion, although the number of reported cases is limited, there appears to be an association between arteritis and the administration of G-CSF, and steroids are an effective therapeutic option.

Entities:  

Keywords:  Arteritis; Granulocyte colony-stimulating factor (G-CSF); Lymphoma

Mesh:

Substances:

Year:  2019        PMID: 31090035     DOI: 10.1007/s12185-019-02662-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  5 in total

1.  A retrospective analysis on arteritis after administration of granulocyte colony-stimulating factor.

Authors:  Ken Sasaki; Kensuke Matsuda; Masashi Miyauchi; Akira Honda; Arika Shimura; Yosuke Masamoto; Mineo Kurokawa
Journal:  Ann Hematol       Date:  2021-03-30       Impact factor: 3.673

2.  Coaxing Anti-Inflammatory Granulocytes to Prevent Ischemic Kidney Injury: A Fine Balance.

Authors:  Alan D Salama; Mark A Little
Journal:  J Am Soc Nephrol       Date:  2020-03-04       Impact factor: 10.121

3.  A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim.

Authors:  Joseph Mort; Shipra Maheshwari; Nayanika Basu; Patrick Dillon; Kevin Brady; Harry Bear; Trish Millard
Journal:  Case Rep Oncol Med       Date:  2022-02-23

4.  Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature.

Authors:  Yukiko Seto; Nobuyoshi Kittaka; Azusa Taniguchi; Haruka Kanaoka; Satomi Nakajima; Yuri Oyama; Hiroki Kusama; Noriyuki Watanabe; Saki Matsui; Minako Nishio; Fumie Fujisawa; Koji Takano; Hideyuki Arita; Takahiro Nakayama
Journal:  Surg Case Rep       Date:  2022-08-12

5.  Granulocyte-Colony Stimulating Factor-Induced Vasculitis Successfully Treated With Short-Term Corticosteroid Therapy: A Case Report.

Authors:  Shintaro Yamamoto; Daisuke Waki; Takeshi Maeda
Journal:  Cureus       Date:  2021-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.